000823949 000__ 03265cam\a2200433Ii\4500
000823949 001__ 823949
000823949 005__ 20230306144057.0
000823949 006__ m\\\\\o\\d\\\\\\\\
000823949 007__ cr\cn\nnnunnun
000823949 008__ 171012s2018\\\\sz\ab\\\ob\\\\001\0\eng\d
000823949 019__ $$a1013497831
000823949 020__ $$a9783319474977$$q(electronic book)
000823949 020__ $$a3319474979$$q(electronic book)
000823949 020__ $$z9783319474960
000823949 0247_ $$a10.1007/978-3-319-47497-7$$2doi
000823949 035__ $$aSP(OCoLC)on1005921905
000823949 035__ $$aSP(OCoLC)1005921905$$z(OCoLC)1013497831
000823949 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dN$T$$dOCLCF$$dAZU$$dOCLCA$$dCOO$$dUAB$$dOCLCQ$$dU3W$$dCAUOI
000823949 049__ $$aISEA
000823949 050_4 $$aRC568.O45
000823949 08204 $$a615.7/822$$223
000823949 1001_ $$aMcAnally, Heath B.,$$eauthor.
000823949 24510 $$aOpioid dependence :$$ba clinical and epidemiologic approach /$$cHeath B. McAnally.
000823949 264_1 $$aCham, Switzerland :$$bSpringer,$$c[2018]
000823949 300__ $$a1 online resource :$$bcolor illustrations, color map
000823949 336__ $$atext$$btxt$$2rdacontent
000823949 337__ $$acomputer$$bc$$2rdamedia
000823949 338__ $$aonline resource$$bcr$$2rdacarrier
000823949 347__ $$atext file$$bPDF$$2rda
000823949 504__ $$aIncludes bibliographical references and index.
000823949 506__ $$aAccess limited to authorized users.
000823949 520__ $$aThis unique and timely title offers a comprehensive assessment of the previously underappreciated risks and potentially overstated benefits of chronic opioid therapy. It does so by approaching the rampant problem of opioid abuse and addiction - currently labeled an epidemic in the United States -- from a public health/epidemiologic perspective. That is, following a thorough overview in Part 1 that compares (and contrasts) classic infectious disease epidemiology concepts with the epidemic, the book categorizes our current understanding of basic science and best clinical practices in opioid therapy in terms of Agent (opioid), Vector (prescriber) and Host (patient) factors. The majority of the book, which includes a plethora of instructional case studies, is organized according to these three arenas. Opioid Dependence: A Clinical and Epidemiologic Approach is designed to update all clinicians on opioid basic science, current areas of drug improvement research and development, alternatives to opioid therapy, evidence-based indications for opioid therapy, and clinical strategies for preventing and overcoming opioid dependence. Importantly, an overview of clinical practice guidelines from the American Society of Addiction Medicine, with its biopsychosocial-spiritual "multidimensional assessment" focus is provided, along with a discussion of medication-assisted treatment, organized by the three currently FDA-approved pharmacotherapeutics (methadone, buprenorphine and naltrexone). Developed for practitioners at every level, this ground-breaking title offers a fresh and novel approach to improving the care and outcomes of patients receiving opioid therapy.
000823949 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed October 17, 2017).
000823949 650_0 $$aOpioid abuse.
000823949 77608 $$iPrint version: $$z9783319474960
000823949 852__ $$bebk
000823949 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-47497-7$$zOnline Access$$91397441.1
000823949 909CO $$ooai:library.usi.edu:823949$$pGLOBAL_SET
000823949 980__ $$aEBOOK
000823949 980__ $$aBIB
000823949 982__ $$aEbook
000823949 983__ $$aOnline
000823949 994__ $$a92$$bISE